NEW YORK (GenomeWeb News) – The National Institute of General Medical Sciences announced yesterday that it has awarded $42.3 million in Grand Opportunities grants to 14 research teams, most of which will use their awards to develop 'omics technologies.

The grants are being funded through the American Recovery and Reinvestment Act, and they support projects at more than 20 research institutions and organizations in 13 states.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

While gene therapies may have high price tags, they could be cheaper than the cost of managing disease, according to MIT's Technology Review.

Researchers are looking for markers that indicate which cancer patients may respond to immunotherapies, the Associated Press writes.

In Nature this week: paternal age associated with de novo mutations in children, and more.

Nature News writes that researchers are still wrangling over the role of the p-value.